Ações do setor de saúde
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 621 |  SEER Seer, Inc. Class A Common Stock | 1.96 USD | +1.03% | +15.98% | +8.29% | -6.22% | 110.58 M USD | ||
| 622 |  PMN ProMIS Neurosciences Inc. Common Shares (ON) | 12.30 USD | +2.07% | +9.33% | -32.23% | +1916.39% | 110.30 M USD | ||
| 623 |  ALDX Aldeyra Therapeutics, Inc. | 1.83 USD | +2.23% | +18.83% | -58.22% | -16.44% | 110.13 M USD | ||
| 624 |  IMDX Insight Molecular Diagnostics Inc. Common Stock | 3.4200 USD | -5.26% | +14.00% | -25.33% | +12.50% | 110.01 M USD | ||
| 625 |  PYXS Pyxis Oncology, Inc. Common Stock | 1.71 USD | +0.59% | +17.12% | +11.04% | +81.91% | 107.44 M USD | ||
| 626 |  RPID Rapid Micro Biosystems, Inc. Class A Common Stock | 2.35 USD | +7.31% | +3.07% | -19.24% | +5.86% | 106.84 M USD | ||
| 627 |  HSDT Solana Company Class A Common Stock (DE) | 1.94 USD | -2.02% | +4.30% | -10.60% | +546.67% | 106.77 M USD | ||
| 628 |  COYA Coya Therapeutics, Inc. Common Stock | 4.53 USD | +1.57% | +9.42% | +1.57% | -16.11% | 106.26 M USD | ||
| 629 |  GOSS Gossamer Bio, Inc. Common Stock | 0.45 USD | +4.65% | +28.57% | 0.00% | -45.78% | 105.61 M USD | ||
| 630 |  AMWL American Well Corporation | 6.2900 USD | +13.05% | +8.45% | +10.35% | +8.68% | 104.11 M USD | ||
| 631 |  VRCA Verrica Pharmaceuticals Inc. Common Stock | 5.9100 USD | +3.32% | +1.55% | -2.96% | -1.83% | 101.53 M USD | ||
| 632 |  CBUS Cibus, Inc. Class A Common Stock | 1.44 USD | +1.41% | -2.04% | -62.01% | -16.76% | 99.64 M USD | ||
| 633 |  ANIX Anixa Biosciences, Inc. | 2.93 USD | +1.74% | +8.12% | +3.17% | +2.09% | 98.24 M USD | ||
| 634 |  CGTX Cognition Therapeutics, Inc. Common Stock | 1.09 USD | +11.22% | +23.86% | +0.93% | +179.49% | 97.40 M USD | ||
| 635 |  VANI Vivani Medical, Inc. Common Stock (DE) | 1.14 USD | +6.54% | +6.54% | -0.87% | +9.62% | 96.50 M USD | ||
| 636 |  STIM Neuronetics, Inc. Common Stock | 1.39 USD | -2.80% | -7.95% | +2.96% | -62.43% | 96.29 M USD | ||
| 637 |  SPRB Spruce Biosciences, Inc. Common Stock | 69.3200 USD | +2.24% | +9.17% | +12.40% | +530.18% | 95.11 M USD | ||
| 638 |  MXCT MaxCyte, Inc. Common Stock | 0.85 USD | -3.41% | +13.33% | +2.41% | -67.31% | 90.83 M USD | ||
| 639 |  HCAT Health Catalyst, Inc Common Stock | 1.2300 USD | +9.82% | +19.42% | -8.89% | -62.04% | 90.51 M USD | ||
| 640 |  GANX Gain Therapeutics, Inc. Common Stock | 2.14 USD | +13.23% | +18.89% | -14.40% | +18.89% | 90.40 M USD |
Notícias Ações do setor de saúde
Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript
VFLO: Free Cash Flow + Growth Is A Winning Formula (NASDAQ:VFLO)
ASML Stock, Astera Labs Among 15 New Stocks On IBD Watchlists
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know
Vivos supera expectativas de lucro do 4º tri de 2025
Jefferies reitera recomendação de compra para BridgeBio Pharma com preço-alvo de US$ 100
Gainers Ações do setor de saúde
 IMMP Immutep Limited American Depositary Shares | 0.54 | +74.19% |
 CUE Cue Biopharma, Inc. | 0.72 | +63.64% |
 NOTV Inotiv, Inc. Common Stock | 0.39 | +56.00% |
 NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
 CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
 NXGL NexGel, Inc Common Stock | 0.76 | +28.81% |
 PDSB PDS Biotechnology Corporation Common Stock | 1.36 | +28.30% |
 TSHA Taysha Gene Therapies, Inc. Common Stock | 6.00 | +27.39% |
Losers Ações do setor de saúde
 WORX SC WORX Corp | 1.06 | -30.72% |
 CMND Clearmind Medicine Inc. Common Shares | 0.65 | -28.57% |
 BEAT Heartbeam, Inc. Common Stock | 0.89 | -25.83% |
 TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0796 | -20.32% |
 JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
 TOIIW The Oncology Institute, Inc. Common Stock | 0.0399 | -18.40% |
 ONCO Onconetix, Inc. Common Stock | 0.7615 | -16.32% |